Apeiron Therapeutics
Burlingame, US · 17 employees on LinkedIn · 2 known investors
Find your way into Apeiron Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
Ask Paul A. Stone to introduce you to Fred Aswad
You →Paul · together at Ideaya Biosciences →Fred
Sign up to find every way you can get introduced to Apeiron Therapeutics
- Your email: who you already know at Apeiron Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Apeiron Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Apeiron Therapeutics is a biotech company developing small-molecule therapeutics with a focus on immuno-oncology and oncology drug discovery. The company operates across the Chinese and global healthcare markets, spanning target identification, medicinal chemistry, and clinical development.
Founders & leadership

Investors · 2
How we know: Sofinnova Ventures's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
In the news
Frequently asked questions
- What does Apeiron Therapeutics do?
- Apeiron Therapeutics is a biotech company developing small-molecule therapeutics with a focus on immuno-oncology and oncology drug discovery. The company operates across the Chinese and global healthcare markets, spanning target identification, medicinal chemistry, and clinical development.
- Who are Apeiron Therapeutics's investors?
- Apeiron Therapeutics's investors include Sofinnova Ventures, Panacea Venture.
- Where is Apeiron Therapeutics headquartered?
- Apeiron Therapeutics is headquartered in Burlingame, US.


